These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11319803)

  • 1. Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution.
    Höglund M; Gisselsson D; Mandahl N; Johansson B; Mertens F; Mitelman F; Säll T
    Genes Chromosomes Cancer; 2001 Jun; 31(2):156-71. PubMed ID: 11319803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
    Mertens F; Johansson B; Höglund M; Mitelman F
    Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical dissection of cytogenetic patterns in lung cancer reveals multiple modes of karyotypic evolution independent of histological classification.
    Höglund M; Gisselsson D; Hansen GB; Mitelman F
    Cancer Genet Cytogenet; 2004 Oct; 154(2):99-109. PubMed ID: 15474144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical analyses of karyotypic complexity in head and neck squamous cell carcinoma.
    Höglund M; Jin C; Gisselsson D; Hansen GB; Mitelman F; Mertens F
    Cancer Genet Cytogenet; 2004 Apr; 150(1):1-8. PubMed ID: 15041216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data.
    Höglund M; Gisselsson D; Soller M; Hansen GB; Elfving P; Mitelman F
    Cancer Genet Cytogenet; 2004 Aug; 153(1):1-9. PubMed ID: 15325087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of chromosomal imbalances in breast cancer delineates cytogenetic pathways and reveals complex relationships among imbalances.
    Höglund M; Gisselsson D; Hansen GB; Säll T; Mitelman F
    Cancer Res; 2002 May; 62(9):2675-80. PubMed ID: 11980667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms tumors develop through two distinct karyotypic pathways.
    Höglund M; Gisselsson D; Hansen GB; Mitelman F
    Cancer Genet Cytogenet; 2004 Apr; 150(1):9-15. PubMed ID: 15041217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinoma develops through multiple modes of chromosomal evolution.
    Höglund M; Gisselsson D; Hansen GB; Säll T; Mitelman F
    Cancer Res; 2003 Jun; 63(12):3378-85. PubMed ID: 12810674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical behavior of complex cancer karyotypes.
    Höglund M; Frigyesi A; Säll T; Gisselsson D; Mitelman F
    Genes Chromosomes Cancer; 2005 Apr; 42(4):327-41. PubMed ID: 15645488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma.
    Höglund M; Säll T; Heim S; Mitelman F; Mandahl N; Fadl-Elmula I
    Cancer Res; 2001 Nov; 61(22):8241-6. PubMed ID: 11719456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting karyotypic patterns in colorectal tumors: two distinct but overlapping pathways in the adenoma-carcinoma transition.
    Höglund M; Gisselsson D; Hansen GB; Säll T; Mitelman F; Nilbert M
    Cancer Res; 2002 Oct; 62(20):5939-46. PubMed ID: 12384560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Karyotypic evolution and tumor progression in head and neck squamous cell carcinomas.
    Jin Y; Jin C; Lv M; Tsao SW; Zhu J; Wennerberg J; Mertens F; Kwong YL
    Cancer Genet Cytogenet; 2005 Jan; 156(1):1-7. PubMed ID: 15588849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data.
    Jiang F; Desper R; Papadimitriou CH; Schäffer AA; Kallioniemi OP; Richter J; Schraml P; Sauter G; Mihatsch MJ; Moch H
    Cancer Res; 2000 Nov; 60(22):6503-9. PubMed ID: 11103820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for karyotypic evolution in testicular germ cell tumors.
    Frigyesi A; Gisselsson D; Hansen GB; Soller M; Mitelman F; Höglund M
    Genes Chromosomes Cancer; 2004 Jul; 40(3):172-8. PubMed ID: 15138997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome abnormalities in human non-small cell lung cancer.
    Testa JR; Siegfried JM
    Cancer Res; 1992 May; 52(9 Suppl):2702s-2706s. PubMed ID: 1314134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas.
    Pei J; Balsara BR; Li W; Litwin S; Gabrielson E; Feder M; Jen J; Testa JR
    Genes Chromosomes Cancer; 2001 Jul; 31(3):282-7. PubMed ID: 11391799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes.
    Kowalski J; Morsberger LA; Blackford A; Hawkins A; Yeo CJ; Hruban RH; Griffin CA
    Cancer Genet Cytogenet; 2007 Oct; 178(1):26-35. PubMed ID: 17889705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution.
    Höglund M; Gisselsson D; Hansen GB; White VA; Säll T; Mitelman F; Horsman D
    Int J Cancer; 2004 Jan; 108(1):57-65. PubMed ID: 14618616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.